目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Therapy
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global HIV Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global HIV Drugs Market 2018 - 2022 ($ billion)
4.2 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
4.3 Therapy segment analysis 2018 - 2022
Historic Market Size - Therapy Segment 2018 - 2022 ($ billion)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel
6.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
6.3 Offline - Market size and forecast 2023-2028
Chart on Offline - Market size and forecast 2023-2028 ($ billion)
Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
Chart on Offline - Year-over-year growth 2023-2028 (%)
Data Table on Offline - Year-over-year growth 2023-2028 (%)
6.4 Online - Market size and forecast 2023-2028
Chart on Online - Market size and forecast 2023-2028 ($ billion)
Data Table on Online - Market size and forecast 2023-2028 ($ billion)
Chart on Online - Year-over-year growth 2023-2028 (%)
Data Table on Online - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ billion)
Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Therapy
7.1 Market segments
Chart on Therapy - Market share 2023-2028 (%)
Data Table on Therapy - Market share 2023-2028 (%)
7.2 Comparison by Therapy
Chart on Comparison by Therapy
Data Table on Comparison by Therapy
7.3 Combination HIV medicines - Market size and forecast 2023-2028
Chart on Combination HIV medicines - Market size and forecast 2023-2028 ($ billion)
Data Table on Combination HIV medicines - Market size and forecast 2023-2028 ($ billion)
Chart on Combination HIV medicines - Year-over-year growth 2023-2028 (%)
Data Table on Combination HIV medicines - Year-over-year growth 2023-2028 (%)
7.4 Integrase inhibitors - Market size and forecast 2023-2028
Chart on Integrase inhibitors - Market size and forecast 2023-2028 ($ billion)
Data Table on Integrase inhibitors - Market size and forecast 2023-2028 ($ billion)
Chart on Integrase inhibitors - Year-over-year growth 2023-2028 (%)
Data Table on Integrase inhibitors - Year-over-year growth 2023-2028 (%)
7.5 Non-nucleoside reverse transcriptase inhibitors - Market size and forecast 2023-2028
Chart on Non-nucleoside reverse transcriptase inhibitors - Market size and forecast 2023-2028 ($ billion)
Data Table on Non-nucleoside reverse transcriptase inhibitors - Market size and forecast 2023-2028 ($ billion)
Chart on Non-nucleoside reverse transcriptase inhibitors - Year-over-year growth 2023-2028 (%)
Data Table on Non-nucleoside reverse transcriptase inhibitors - Year-over-year growth 2023-2028 (%)
7.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ billion)
Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Therapy
Market opportunity by Therapy ($ billion)
Data Table on Market opportunity by Therapy ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ billion)
Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ billion)
Data Table on US - Market size and forecast 2023-2028 ($ billion)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ billion)
Data Table on China - Market size and forecast 2023-2028 ($ billion)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ billion)
Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. - Overview
Aurobindo Pharma Ltd. - Product / Service
Aurobindo Pharma Ltd. - Key offerings
12.5 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.6 Cadila Pharmaceuticals Ltd.
Cadila Pharmaceuticals Ltd. - Overview
Cadila Pharmaceuticals Ltd. - Product / Service
Cadila Pharmaceuticals Ltd. - Key offerings
12.7 Cipla Inc.
Cipla Inc. - Overview
Cipla Inc. - Business segments
Cipla Inc. - Key news
Cipla Inc. - Key offerings
Cipla Inc. - Segment focus
12.8 Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. - Overview
Emcure Pharmaceuticals Ltd. - Product / Service
Emcure Pharmaceuticals Ltd. - Key offerings
12.9 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product / Service
Gilead Sciences Inc. - Key news
Gilead Sciences Inc. - Key offerings
12.10 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.11 Hetero Labs Ltd.
Hetero Labs Ltd. - Overview
Hetero Labs Ltd. - Product / Service
Hetero Labs Ltd. - Key offerings
12.12 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.13 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Product / Service
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
12.14 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.15 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global HIV Drugs Market 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Therapy Segment 2018 - 2022 ($ billion)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits33: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Distribution Channel
Exhibits35: Data Table on Comparison by Distribution Channel
Exhibits36: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibits37: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibits38: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Offline - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Online - Market size and forecast 2023-2028 ($ billion)
Exhibits41: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
Exhibits42: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Distribution Channel ($ billion)
Exhibits45: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits46: Chart on Therapy - Market share 2023-2028 (%)
Exhibits47: Data Table on Therapy - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Therapy
Exhibits49: Data Table on Comparison by Therapy
Exhibits50: Chart on Combination HIV medicines - Market size and forecast 2023-2028 ($ billion)
Exhibits51: Data Table on Combination HIV medicines - Market size and forecast 2023-2028 ($ billion)
Exhibits52: Chart on Combination HIV medicines - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Combination HIV medicines - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Integrase inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibits55: Data Table on Integrase inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibits56: Chart on Integrase inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Integrase inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Non-nucleoside reverse transcriptase inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibits59: Data Table on Non-nucleoside reverse transcriptase inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibits60: Chart on Non-nucleoside reverse transcriptase inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Non-nucleoside reverse transcriptase inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits63: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits66: Market opportunity by Therapy ($ billion)
Exhibits67: Data Table on Market opportunity by Therapy ($ billion)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits102: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits103: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits106: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits107: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ billion)
Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits111: Impact of drivers and challenges in 2023 and 2028
Exhibits112: Overview on criticality of inputs and factors of differentiation
Exhibits113: Overview on factors of disruption
Exhibits114: Impact of key risks on business
Exhibits115: Companies covered
Exhibits116: Matrix on companies position and classification
Exhibits117: AbbVie Inc. - Overview
Exhibits118: AbbVie Inc. - Product / Service
Exhibits119: AbbVie Inc. - Key news
Exhibits120: AbbVie Inc. - Key offerings
Exhibits121: Aurobindo Pharma Ltd. - Overview
Exhibits122: Aurobindo Pharma Ltd. - Product / Service
Exhibits123: Aurobindo Pharma Ltd. - Key offerings
Exhibits124: Bristol Myers Squibb Co. - Overview
Exhibits125: Bristol Myers Squibb Co. - Product / Service
Exhibits126: Bristol Myers Squibb Co. - Key news
Exhibits127: Bristol Myers Squibb Co. - Key offerings
Exhibits128: Cadila Pharmaceuticals Ltd. - Overview
Exhibits129: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits130: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits131: Cipla Inc. - Overview
Exhibits132: Cipla Inc. - Business segments
Exhibits133: Cipla Inc. - Key news
Exhibits134: Cipla Inc. - Key offerings
Exhibits135: Cipla Inc. - Segment focus
Exhibits136: Emcure Pharmaceuticals Ltd. - Overview
Exhibits137: Emcure Pharmaceuticals Ltd. - Product / Service
Exhibits138: Emcure Pharmaceuticals Ltd. - Key offerings
Exhibits139: Gilead Sciences Inc. - Overview
Exhibits140: Gilead Sciences Inc. - Product / Service
Exhibits141: Gilead Sciences Inc. - Key news
Exhibits142: Gilead Sciences Inc. - Key offerings
Exhibits143: GlaxoSmithKline Plc - Overview
Exhibits144: GlaxoSmithKline Plc - Business segments
Exhibits145: GlaxoSmithKline Plc - Key news
Exhibits146: GlaxoSmithKline Plc - Key offerings
Exhibits147: GlaxoSmithKline Plc - Segment focus
Exhibits148: Hetero Labs Ltd. - Overview
Exhibits149: Hetero Labs Ltd. - Product / Service
Exhibits150: Hetero Labs Ltd. - Key offerings
Exhibits151: Johnson and Johnson Services Inc. - Overview
Exhibits152: Johnson and Johnson Services Inc. - Business segments
Exhibits153: Johnson and Johnson Services Inc. - Key news
Exhibits154: Johnson and Johnson Services Inc. - Key offerings
Exhibits155: Johnson and Johnson Services Inc. - Segment focus
Exhibits156: Lupin Ltd. - Overview
Exhibits157: Lupin Ltd. - Product / Service
Exhibits158: Lupin Ltd. - Key news
Exhibits159: Lupin Ltd. - Key offerings
Exhibits160: Merck and Co. Inc. - Overview
Exhibits161: Merck and Co. Inc. - Business segments
Exhibits162: Merck and Co. Inc. - Key news
Exhibits163: Merck and Co. Inc. - Key offerings
Exhibits164: Merck and Co. Inc. - Segment focus
Exhibits165: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits166: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits167: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits168: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits169: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits170: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits171: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits172: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits173: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits174: Viatris Inc. - Overview
Exhibits175: Viatris Inc. - Business segments
Exhibits176: Viatris Inc. - Key news
Exhibits177: Viatris Inc. - Key offerings
Exhibits178: Viatris Inc. - Segment focus
Exhibits179: Inclusions checklist
Exhibits180: Exclusions checklist
Exhibits181: Currency conversion rates for US$
Exhibits182: Research methodology
Exhibits183: Information sources
Exhibits184: Data validation
Exhibits185: Validation techniques employed for market sizing
Exhibits186: Data synthesis
Exhibits187: 360 degree market analysis
Exhibits188: List of abbreviations